Investment

Le fabricant de médicaments avait suspendu des projets à grande échelle au Royaume-Uni, mais s'est désormais engagé à investir sur deux sites, comme annoncé par Keir Starmer. AstraZeneca, le plus grand fabricant de médicaments de Grande-Bretagne, a déclaré qu'il investirait 300 millions de livres sterling au Royaume-Uni, un revirement surprise après avoir mis en pause des projets d'envergure l'année dernière. Le groupe avait retiré des projets en Grande-Bretagne après s'être désillusionné quant à l'environnement commercial, notamment en ce qui concerne la disponibilité des nouveaux médicaments au sein du NHS et la tarification des médicaments. Lire la suite...

• Pharmaceutical giants Eli Lilly and Pfizer announced a strategic research collaboration focusing on oncology and immunology, with combined commitments totaling $4.8 billion over five years to accelerate drug development and clinical trial timelines. • The partnership will leverage Eli Lilly's metabolic disease expertise and Pfizer's vaccine platform capabilities to pursue combination therapies for hard-to-treat cancers, with initial clinical trials expected to commence in mid-2027. • Industry analysts view the deal as emblematic of Big Pharma consolidating R&D resources amid rising drug development costs exceeding $2.6 billion per approved medication, while also signaling confidence in oncology market growth.

• Brazil has suspended a $4 billion Chinese investment in Amazon infrastructure projects following international pressure over deforestation and environmental protection commitments. • President Lula cited insufficient environmental safeguards and lack of transparency in project oversight as the primary reasons for the suspension announced Friday. • Environmental groups and US officials praised the decision, though economic analysts warn the suspension could strain Brazil-China relations and impact Latin American development patterns.

• Global private markets platform Moonfare announced a new AI-focused technology strategy targeting early and growth-stage investments for diversified US-relevant AI exposure. • Strategy features curated portfolio of leading growth managers plus direct investments in category-leading US technology companies driving AI innovation. • Aims to capitalize on transformative AI advancements, providing investors access to high-potential startups in the booming sector.

• Fraud incidents continue climbing at US banks even with substantial spending on advanced detection tools and analytics. • The gap highlights limitations in current tech defenses against evolving fraudster tactics. • This trend matters as it pressures financial institutions to innovate faster, amid rising economic impacts from cyber fraud.

Technology secretary plays down fears over jobs and cyber security as stake taken in British startupThe UK technology secretary has urged the country to “make AI work for Britain”, brushing off fears about its impact on jobs and cybersecurity as the government announced its first investment under a £500m sovereign AI fund. Liz Kendall said the UK had to “seize” the opportunity offered by AI despite concerns underlined this month when US startup Anthropic revealed it had developed an AI model that posed a potentially significant cyber threat. Asked how the government makes the case for embracing a technology that could disrupt jobs and now cybersecurity, Kendall said: “We have to seize this to make it work, for Britain, for our jobs, for solving the biggest challenges we face as a world.”Speaking on Thursday as the government unveiled its first investment in a UK company as part of a £500m sovereign AI fund, Kendall acknowledged “people are worried about the risks and what it means for their jobs”, but AI entrepreneurs also believed they can “make it work … they can create jobs”. Continue reading...

• A survey by AirMDR released on April 14, 2026, in Palo Alto, CA, reveals 80% of US-based cybersecurity investors intend to increase AI cybersecurity funding next year. • 71% expect decisive ROI from AI tools, with capital shifting toward companies proving operational impact and cost reductions over mere product enhancements. • Investors prioritize defensible AI technologies delivering real outcomes, signaling strong market confidence but heightened selectivity for enterprise-ready solutions.

Exclusive: US state is targeting corporate heavyweights in the UK with subsidies and incentives Y’all Street: Bullish Dallas aims to steal New York’s crownThe US state of Texas is putting UK businesses in its crosshairs with the launch this month of a dedicated London office to lure jobs and investment to the low-tax Lone Star State.Texas recently secured approval for the new site, adding to a growing list of international offices from which it can try to draw corporate heavyweights across its borders. Continue reading...